SLINGSHOT

For a momentum trader? The 3 month chart is basically lingerie. $CLOV

$CLOV That giant $3.32 wall on Level 2? Shorts may discover what repricing feels like in Real Time #FuckAroundAndFindOut

$CLOV …controlled continuation. Will early longs use the $3 break to take profits? Technically, this looks more like accumulation than exhaustion right now. The fact it’s doing this while futures were shaky overnight makes it even more notable.

Now suddenly: - dips are getting bought - volume is expanding - sentiment is shifting - profitability arrived sooner than expected - and social media attention is waking back up Thats how violent trend reversals start. Not when everyone believes. When nobody trusts the move yet.

What most people still don’t understand about $CLOV: The danger to shorts isn’t just the earnings. It’s the setup. For YEARS this stock trained investors to sell every rally. 👇🏼👇🏼

@mo32564305 @AlbertAlan 😂

@AlbertAlan Fixed it, lol.

$CLOV Something is happening with Clover Health. This is the daily volume of posts and conversations mentioning the company over the past week. Flat for days. Then nearly vertical into today. Here is what changed underneath. Q1 2026 delivered the strongest GAAP net income quarter in company history. Management issued full year GAAP profitability guidance for the first time ever. Counterpart Health is shifting from concept into real deployment as the AI infrastructure layer underneath value based care. The stock has run roughly 80 percent off what some are starting to call a second bottom. The attention is now arriving. Institutional desks. Retail timelines. Bar stools. Not telling anyone what to do. Just pointing at what I see. The open question is when the broader market decides to rerate the equity to match what the business is actually doing. What are you seeing?

@ChartCodex People laugh at charts like this until fundamentals catch up to price. At $1.60 $CLOV was priced for dead. Now? profitable hyper growth strong MA expansion sentiment reversal volume returning Does it guarantee $8-$12? No But when a stock survives, then starts thriving…🚀✨🌗

$CLOV – Langfristiges Bild Nach dem Tief der Welle 2 bei rund 1,60 USD hat $CLOV eine kräftige Rally von knapp 100 % hingelegt. Dabei wurden die gleitenden Durchschnitte ohne großen Widerstand überwunden – ein erstes konstruktives Signal. Für eine nachhaltige Trendwende und eine gesunde Fortsetzung der Aufwärtsbewegung braucht es nun jedoch eine saubere Korrektur in einer ABC‑Struktur. Entscheidend ist, wie sich der Kurs in der relevanten Unterstützungszone verhält. Kann dort ein Higher Low ausgebildet werden, wäre das für mich die Bestätigung der Trendwende. Langfristig liegen die Ziele der übergeordneten Wellenstruktur bei: Welle 3: 8,2 USD Welle 5: 12,3 USD

Vanguard subsidiaries now report holdings separately instead of under the parent “The Vanguard Group” umbrella. So if you see a “0 shares” headline pop up it’s more of a reporting/accounting change. Vanguard-related holdings hold around 24 million shares in $CLOV

To the $CLOV shorts ask yourself sellers. Ask yourself one question: “Do I feel lucky?”

I neglected to mention what is also important. Look at the volume profile of $CLOV over the past few sessions it’s stair stepping higher. That tells me attention is growing organically not just one random candle. 🚀✨🌗 #Weekend #Reddit #CLOV

The MOST bullish thing that could happen now: $CLOV closes strong today, holds the upper $2.90s, and traders spend all weekend staring at a chart parked right beneath $3. 👀 Because then Monday stops being: “Should I buy CLOV?” …and becomes: “What happens IF this breaks $3?”

@AlbertAlan @ALSTOCKTRADES $CLOV 😂👍🏼

They told you $CLOV was dead. April 30th. Sentiment got obliterated. Headlines red. Retail bleeding. Every "guru" newsletter screaming exit at the exact bottom. I watched the data flip in real time. While the herd ran for the doors, sentiment quietly cratered to negative 1.8. Then came the violent reversal. Straight up. Highest reading in a year. Positive 2.3. Stock sitting at $2.82 with a net bullish score of 0.73 across 85 articles. But this post isn't really about $CLOV. It's about the gap between broke and rich. I came from nothing. Places I won't talk about. Now I'm a multi-millionaire. And the thing that changed wasn't luck. Wasn't connections. Wasn't legacy Harvard admissions. Wasn't daddy's bank account. It was the mind. A winner has the psychological fortitude of a machine. Unbothered by noise. Unswayed by panic. Unmoved by the loudest voice in the room, which is almost always wrong. You are where you are because you let other people dictate how you live. Wall Street says sell, you sell. CNBC says panic, you panic. Reddit says it's over, you tap out at the bottom. Not me. I don't read emotions. I read data. Every angry tweet, every bearish headline, every "this stock is finished" comment is a data point. The herd's panic is my staircase up the mountain. I get a finite number of days on this rock. I plan to take the most out of every one of them. Harm nobody. Help a lot of people. And win, because winners win. Stay sharp. Stay data driven. Stay dangerous.

$3 on $CLOV will probably be a war. Profit takers, bagholders, shorts, and algos will all attack. That’s normal. But if buyers absorb the selling and hold above $3 with volume? That’s when social media, momentum scanners, etc weekend hype start pouring gasoline on the fire.

If $CLOV wins the Star lawsuit That's ~$150M in restored revenue. Compounding. Every year. $4.50–$5.00 in 2 sessions, not 2 quarters. In my opinion, get ready to kick some tires!

$CLOV 🙏 Fundamental analysis > Emotions

I was asked what is “Repricing”?its when the market suddenly realizes a company may be worth far more than believed. $CLOV was priced like a struggling meme stock. Now? 🦉profitable 🦉growing 62% 🦉expanding fast 🦉holding gains AFTER earnings That’s how repricing starts.

$CLOV had every excuse to fail after earnings… Instead: 🪿profitable quarter 🐦‍⬛+62% revenue growth 🕊️buyers defending dips 🦅momentum building now flirting with $3 This no longer looks like survival mode. It looks like repricing.

In Dec 2023 people were panic selling $INTC at $18-$19. Now it’s trading at $116-$117 and everyone’s chasing it up like they “always knew.” That’s the market. Weak hands sell fear. The crowd buys confirmation. Stocks like $CLOV can go through the same cycle. Never doubt DOUBT

Tomorrow: If $CLOV holds above $2.75 and attacks $2.90 again, then $3 starts looking very real. And once stocks flirt with whole-dollar breakouts after strong earnings… momentum traders come flooding in like pigeons fighting over french fries. 🍟🪿🐦‍⬛

That late volume surge on $CLOV matters. It suggests: People are still positioning Attention is increasing and traders aren’t walking away after earnings. Shorts are 💩’ing 😂